Inflammasome triggers or amplify liver diseases by releasing pro-inflammatory cytokines such as IL-1β, IL-1α, IL-18, and also through other inflammatory mediators such as High Mobility Group Box 1 (HMGB1) (35). This evidence concerns the gene IL1B and liver disorder.